Latest Breaking News On - Tadashi watabe - Page 2 : vimarsana.com

New radio-theranostics approach shows promise in the fight against pancreatic cancer

Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers worldwide, with a 5-year survival rate of less than 10%. Many PDAC tumors in early stage go undetected because they are not found using conventional imaging methods, including fluorodeoxyglucose positron emission tomography (PET) scans.

Tadashi watabeLily ramseyKazuya kabayamaOsaka universityJournal of nuclear medicineNuclear medicineMonoclonal antibodyNuclear medicinePancreatic cancerPositron emission tomography

Powerful New Weapon Unleashed in Battle Against Deadly Cancer

Powerful New Weapon Unleashed in Battle Against Deadly Cancer
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Tadashi watabeKazuya kabayamaOsaka universityJournal of nuclear medicineNuclear medicine

Radio-theranostics strategy offers a powerful new tool in the fight against pancreatic cancer

Radio-theranostics strategy offers a powerful new tool in the fight against pancreatic cancer
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Tadashi watabeKazuya kabayamaTadashi watabe osaka universityOsaka universityJournal of nuclear medicineNuclear medicineTherapy using antiTheranostic approachPancreatic ductal adenocarcinoma

Targeting refractory prostate cancer: novel radiopharmaceutical hits bull s-eye

Targeting refractory prostate cancer: novel radiopharmaceutical hits bull s-eye
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Frederikl gieselTadashi watabeOsaka universityTadashi watabe osaka universityEuropean journal of nuclear medicineJapan agency for medical researchDusseldorf universityEuropean journalNuclear medicineMolecular imagingJapan agencyMedical research

New radiopharmaceutical shrinks prostate cancer tumors

A new radiopharmaceutical treatment shrinks prostate cancer tumors, according to researchers in Japan and Germany.

Frederikl gieselTadashi watabeOsaka universityEuropean journal of nuclear medicineJapan agency for medical researchDusseldorf universityEuropean journalNuclear medicineMolecular imagingJapan agencyMedical research